Tag: Lung
Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market is anticipated to surpass…...
Newark, New Castle, USA, March 22, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the...
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy...
MannKind will conduct formulation and preclinical studies of a new chemical entity owned by Thirona In addition, MannKind purchased a convertible note issued...
MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166...
LA JOLLA, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV)...
G1 Therapeutics Presents Data on COSELA™ (trilaciclib) at ASCO on Potential...
RESEARCH TRIANGLE PARK, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today presented results from...
G1 Therapeutics Presents Two Posters at ISPOR Describing the Estimated Economic...
- A Cost-Benefit Model of Administration of COSELATM (trilaciclib) Prior to Chemotherapy Estimates Measurable Per-Patient Cost Savings - - Myelosuppression Poses a...
With humor, insight, and charm, Annabelle Gurwitch shares her lung cancer...
Los Angeles, California, May 06, 2021 (GLOBE NEWSWIRE) -- Fans of author, actor, and activist Annabelle Gurwitch will immediately recognize her...
G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program...
- Pivotal Program Evaluated the Effects of Administering COSELA Prior to Chemotherapy on Clinically Relevant Endpoints Across Multiple Hematopoietic Lineages, Including Hematologic Adverse...
Japanese docs carry out world’s first dwelling donor lung transplant to...
Kyoto University Hospital said the woman underwent an 11-hour operation by a 30-strong medical team on Wednesday to transplant lung tissue from her...
aTyr Pharma Presents Preclinical Research Showing Effects of ATYR2810 in Lung...
Findings demonstrate tumor inhibitory effects of ATYR2810 when used as a monotherapy or in combination with chemotherapy in models of non-small cell lung...